Cargando…

Meta-analysis comparing maintenance strategies with continuous therapy and complete chemotherapy-free interval strategies in the treatment of metastatic colorectal cancer

There is as yet no consensus as to the best choice among the three treatment options (maintenance, complete chemotherapy-free intervals [CFIs], and continuous) for metastatic colorectal cancer (CRC). We performed a meta-analysis of six trials (N = 2, 454 patients) to compare the safety and efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Lei, Wang, Jing, Li, Huihui, Che, Juanjuan, Cao, Bangwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078106/ https://www.ncbi.nlm.nih.gov/pubmed/27072579 http://dx.doi.org/10.18632/oncotarget.8644

Ejemplares similares

Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma
por: Abe, T, et al.
Publicado: (2019)

Erratum to: Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma
por: Abe, T, et al.
Publicado: (2020)

Cronkhite-Canada syndrome associated with colon cancer metastatic to liver: A case report
por: Wang, Jing, et al.
Publicado: (2017)

SLC27A2 mediates FAO in colorectal cancer through nongenic crosstalk regulation of the PPARs pathway
por: Shang, Kun, et al.
Publicado: (2023)

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
por: Shi, Min, et al.
Publicado: (2020)

Isolation and Identification of miRNAs in exosomes derived from serum of colon cancer patients
por: Zhao, Lei, et al.
Publicado: (2017)

Safety and Efficacy of Tianfoshen Oral Liquid in Non-Small Cell Lung Cancer Patients as an Adjuvant Therapy
por: Zhao, Lei, et al.
Publicado: (2019)

Risk of immune-related diarrhea with PD-1/PD-L1 inhibitors in different cancer types and treatment regimens
por: Zhao, Lei, et al.
Publicado: (2020)

Long non-coding RNA H19, a novel therapeutic target for pancreatic cancer
por: Wang, Jing, et al.
Publicado: (2020)

Decreased expression of Dlg5 is associated with a poor prognosis and epithelial–mesenchymal transition in squamous cell lung cancer
por: Che, Juanjuan, et al.
Publicado: (2021)

Rechallenge and maintenance therapy using cetuximab and chemotherapy administered to a patient with metastatic colorectal cancer
por: Ma, Jian, et al.
Publicado: (2017)

Efficacy and safety of metronomic chemotherapy in maintenance therapy for metastatic colorectal cancer: A systematic review of randomized controlled trials
por: Chen, Li, et al.
Publicado: (2022)

Time-Tested Strategies in Modern Context: A Bibliometric Study of Chemotherapy’s Continued Importance in Colorectal Cancer Treatment
por: Clar-Marmaneu, Helena, et al.
Publicado: (2023)

A Meta-Analysis and Systematic Review on the Association between Human Papillomavirus (Types 16 and 18) Infection and Esophageal Cancer Worldwide
por: Wang, Jing, et al.
Publicado: (2016)

Prolonged Complete Response in a Patient with Metastatic Pancreatic Adenocarcinoma after FOLFIRINOX Chemotherapy and Maintenance with FOLFIRI
por: Nikolaou, Christos, et al.
Publicado: (2015)

Comparative Effectiveness of Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer
por: Satram-Hoang, Sacha, et al.
Publicado: (2012)

Strategies to tackle RAS-mutated metastatic colorectal cancer
por: Patelli, G., et al.
Publicado: (2021)

Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
por: Yoneoka, Yutaka, et al.
Publicado: (2019)

Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer
por: Zhao, Lei, et al.
Publicado: (2017)

BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic options
por: Hummel, Michael, et al.
Publicado: (2021)

Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis
por: Moriwaki, Toshikazu, et al.
Publicado: (2021)

Efficacy and Safety of Bevacizumab Combined with Chemotherapy for Managing Metastatic Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Li, Qin, et al.
Publicado: (2015)

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
por: Grassi, Elisa, et al.
Publicado: (2021)

Improving Outcomes for Patients With Metastatic Colorectal Cancer: Challenges and Strategies
por: Swanson, Leslie A., et al.
Publicado: (2020)

The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic Analysis
por: Yan, Han, et al.
Publicado: (2015)

Latency and interval therapy affect the evolution in metastatic colorectal cancer
por: Nikbakht, Hamid, et al.
Publicado: (2020)

Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival
por: Homayounfar, K., et al.
Publicado: (2013)

Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities
por: Porru, Manuela, et al.
Publicado: (2018)

Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer
por: Baraibar, Iosune, et al.
Publicado: (2021)

Continuous Improvement Strategies
por: Hopper, Anthony
Publicado: (2018)

Dietary Strategies for Weight Loss Maintenance
por: van Baak, Marlene A., et al.
Publicado: (2019)

Strategy maintenance in smart healthcare systems
por: Boujelben, Abir, et al.
Publicado: (2023)

Examining the effectiveness of different dental recall strategies on maintenance of optimum oral health: the INTERVAL dental recalls randomised controlled trial
por: Clarkson, Jan E., et al.
Publicado: (2021)

Number of periodic orbits in continuous maps of the interval: complete solution of the counting problem
por: Hao, B L
Publicado: (1999)

Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates
por: Zmuc, Jan, et al.
Publicado: (2023)

Expert consensus on maintenance treatment for metastatic colorectal cancer in China
por: Xu, Rui-Hua, et al.
Publicado: (2016)

MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER
por: Dufresne, Armelle, et al.
Publicado: (2008)

Comparative Effectiveness of Up To Three Lines of Chemotherapy Treatment Plans for Metastatic Colorectal Cancer
por: Toumazis, Iakovos, et al.
Publicado: (2017)

Proactive strategies for regorafenib in metastatic colorectal cancer: implications for optimal patient management
por: Khan, Gazala, et al.
Publicado: (2014)

Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer
por: Tonini, Giuseppe, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8n0ttrgomuogdn0lf0papraa48